Development of breeding media production platform for the production of monoclonal antibodies
Number_reference_aid_programme: SA.41471(2015/X) Purpose of public aid: art: 25 EC Regulation No 651/2014 of 17 June 2014 declaring certain categories of aid compatible with the internal market in the application of Articles 107 and 108 of the Treaty (OJ L 119, p. That’s it. EU L 187/1 of 26.06.2014.In the framework of the project (Project and project) Polpharma Biologics (hereinafter: &bdquo;Company &rdquo;, &bdquo;The Applicant &rdquo;) will conduct industrial research and development work aimed at developing an innovative platform of base breeding media and supplements used in the development and subsequent production of therapeutic monoclonal antibodies. The technology will improve the production of biosimilar drugs. The result of the Project will allow to obtain proteins with the desired quality parameters, and thus increase the productivity of the process of production of therapeutic antibodies. In order to achieve the project’s expected results, 4 research tasks &ndash; 3 stages of industrial research and 1 stage of development. Within 3 years of the completion of the Project, its results will be implemented in the Company’s activities (by introducing the results of industrial research and development into the Applicant’s own business activity). The results of the Project will constitute an important know-how, which is the basis for the implementation of further advanced research projects &ndash; development of development.